Computational analysis of epigenetic patterns facilitates diagnosis of unknown hereditary disorders
A new sophisticated computational model, developed by scientists at Lawson Health Research Institute, is bringing an innovative method of diagnosing rare hereditary conditions.
Genome-wide testing of DNA methylation, a mechanism of the epigenome, has been shown to facilitate the diagnosis of previously unsolved cases of neurodevelopmental or congenital abnormalities. The epigenome is any process that can change the expression of a gene without changing the gene sequence.
The latest in a series of research publications around the theme of epigenomic testing applied the new pattern recognition model to DNA samples of 965 patients with neurodevelopmental and congenital anomalies that did not have a definitive diagnosis despite extensive clinical genetic testing. Their DNA, acquired through blood samples, was examined using the new model, and dozens of new cases were resolved.
Current testing of patients who present with neurodevelopmental and congenital anomalies leaves a number of cases undiagnosed or unexplained. “Many families spend years going through repeated testing and assessments, in search of a diagnosis. This process is hard on patients and families, and is a great cost to our health care system,” explains Dr. Bekim Sadikovic, Associate Scientist at Lawson, and Head of the Molecular Genetics Division in the Department of Pathology and Laboratory Medicine, London Health Sciences Centre (LHSC).
While currently there are limited treatment options associated with many of these conditions, providing a specific diagnosis can help physicians better predict the course of the disease, allowing for better planning and support for the patient. This research highlights the value of epigenomic testing in the routine assessment of neurodevelopmental and congenital disorders.
From this research, LHSC will be the first site in the world to offer this type of genetic testing. “We are excited to make this testing accessible to local patients, and across the world. Our lab has partnered and licensed this technology to Greenwood Genetics Laboratories in the United States and Amsterdam University Medical Centre Laboratories in the European Union”, says Dr. Sadikovic. 100 per cent of revenue will be funneled back to support local testing for patients and ongoing research.
Learn more: Research leads to new molecular diagnostic tool
The Latest on: Molecular diagnostic tool
[google_news title=”” keyword=”molecular diagnostic tool” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Molecular diagnostic tool
- Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22qon April 26, 2024 at 10:18 am
A recent study led by UC Davis Health researchers provides new insights into the molecular changes linked to the rare genetic condition 22q11.2 deletion syndrome, or 22q. It found unique biomarkers ...
- Blood-Based Biomarker Warns of Arthritic Knees Years in Advanceon April 25, 2024 at 5:00 pm
Kraus and colleagues have focused on developing molecular biomarkers that can be used for both clinical diagnostic purposes and as a research tool to aid in the development of effective drugs. In ...
- Life Science Tools Market To Reach USD 400.2 Billion By 2032 | DataHorizzon Researchon April 25, 2024 at 10:59 am
The life science tools market size was valued at USD 162.4 Billion in 2023 and is expected to reach a market size of USD 400.2 Billion by 2032 at a CAGR of 10.5%.Fort Collins, Colorado, April 25, 2024 ...
- AI-MARRVEL: New AI Accelerates Diagnosis of Rare Genetic Disorderson April 25, 2024 at 6:00 am
AIM, developed by Baylor College of Medicine, enhances genetic diagnosis accuracy and speed by prioritizing causative variants in rare diseases, showing superior results compared to other methods.
- Vietnam PoC Molecular Diagnostic Market Future Ascent Market Size’s Journey to Unseen Heightson April 24, 2024 at 2:19 pm
Report Ocean’s latest analysis delves into the “Vietnam PoC Molecular Diagnostic Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, ...
- Vietnam Molecular Diagnostic Market Upcoming Peaks Market Size’s Projection to Reach New Heightson April 24, 2024 at 2:16 pm
Report Ocean’s latest analysis delves into the “Vietnam Molecular Diagnostic Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, segmentation, ...
- A molecular fingerprint beyond the Nyquist frequencyon April 23, 2024 at 5:00 pm
real-time environmental monitoring and open-air diagnostics of toxic and hazardous gases, and molecular endoscopy," says Dr. Hanieh Fattahi. The work is published in the journal Ultrafast Science.
- 'Game-changer' in molecular imaging within sighton April 23, 2024 at 6:29 am
THUNDER BAY – A technique being refined by researchers in Thunder Bay that provides razor sharp images of the lungs and blood flow images of the brain could revolutionize the future of personalized ...
- As Molecular Testing Expands, Labs Find Reimbursement Process Becoming a Herculean Taskon April 22, 2024 at 7:50 am
Laboratories and lab consultants said that they have seen in recent years a more adversarial and uncertain reimbursement process fraught with delays, denials, and added labor.
- PRED Predictive Technology Group, Inc.on April 15, 2024 at 5:00 pm
It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global ...
via Bing News